Literature DB >> 8348144

Erythropoietin receptor mutations and Olympic glory.

G D Longmore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8348144     DOI: 10.1038/ng0693-108

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  5 in total

Review 1.  Hematopoietic growth factors, signaling and the chronic myeloproliferative disorders.

Authors:  Kenneth Kaushansky
Journal:  Cytokine Growth Factor Rev       Date:  2006-10-20       Impact factor: 7.638

Review 2.  The JAK2(V617F) tyrosine kinase mutation in myeloproliferative disorders: Summary of published literature and a perspective.

Authors:  Martha Wadleigh; D Gary Gilliland
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

Review 3.  From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?

Authors:  Giuseppe Fischetto; Stéphane Bermon
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

Review 4.  The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54 year old speculation comes of age.

Authors:  Kenneth Kaushansky
Journal:  Best Pract Res Clin Haematol       Date:  2007-03       Impact factor: 3.020

5.  Transmission Distortion of MCT1 rs1049434 among Polish Elite Athletes.

Authors:  Magdalena Dzitkowska-Zabielska; Aleksandra Bojarczuk; Małgorzata Borczyk; Marcin Piechota; Michał Korostyński; Jakub Grzegorz Adamczyk; Grzegorz Trybek; Myosotis Massidda; Paweł Cięszczyk
Journal:  Genes (Basel)       Date:  2022-05-12       Impact factor: 4.141

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.